Prenetics Global Limited (NASDAQ:PRE) Sees Large Increase in Short Interest

Posted by Casey Walker on Jun 17th, 2025

Prenetics Global Limited (NASDAQ:PRE – Get Free Report) saw a large growth in short interest during the month of May. As of May 31st, there was short interest totalling 34,500 shares, a growth of 46.2% from the May 15th total of 23,600 shares. Based on an average daily volume of 21,200 shares, the short-interest ratio is presently 1.6 days. Currently, 0.4% of the company’s shares are sold short.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Prenetics Global stock. Nomura Holdings Inc. raised its stake in shares of Prenetics Global Limited (NASDAQ:PRE – Free Report) by 3.3% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 333,528 shares of the company’s stock after purchasing an additional 10,576 shares during the period. Nomura Holdings Inc. owned 2.73% of Prenetics Global worth $1,307,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 25.01% of the company’s stock.

Prenetics Global Price Performance

PRE stock traded up $0.60 during midday trading on Tuesday, hitting $7.61. The stock had a trading volume of 1,366 shares, compared to its average volume of 19,058. Prenetics Global has a 12-month low of $3.09 and a 12-month high of $11.99. The firm has a market cap of $92.82 million, a PE ratio of -1.91 and a beta of 0.17. The company’s 50-day moving average price is $6.39 and its 200 day moving average price is $5.54.

Prenetics Global (NASDAQ:PRE – Get Free Report) last released its earnings results on Thursday, June 12th. The company reported ($0.80) EPS for the quarter. Prenetics Global had a negative net margin of 191.73% and a negative return on equity of 16.45%. The business had revenue of $17.31 million during the quarter. As a group, sell-side analysts anticipate that Prenetics Global will post -3.3 EPS for the current year.

Prenetics Global Company Profile

(Get Free Report)

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies.